Back to top

Image: Bigstock

Why Callaway Golf (ELY) Stock Might be a Great Pick

Read MoreHide Full Article

One stock that might be an intriguing choice for investors right now is Callaway Golf Company . This is because this security in the Leisure and Recreation Products space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Leisure and Recreation Products space as it currently has a Zacks Industry Rank of 30 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.

Meanwhile, Callaway Golf is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term.

Callaway Golf Company Price and Consensus

In fact, over the past two months, current quarter estimates have risen from 35 cents per share to 51 cents per share, while current year estimates have risen from 60 cents per share to 70 cents per share. This has helped ELY to earn a Zacks Rank #2 (Buy), further underscoring the company’s solid position. You can see  the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So, if you are looking for a decent pick in a strong industry, consider Callaway Golf. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>

Published in